Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008
Monika Brüggemann(University Hospital Schleswig-Holstein), Renato Bassan(Pittini Group (Italy)), Jacques J. M. van Dongen(Universidad de Salamanca), Robin Foà(Sapienza University of Rome), Hélène Cavé(Hôpital Robert-Debré), André Baruchel(Université Paris Cité), Orietta Spinelli(Ospedale Papa Giovanni XXIII), Martin Schrappe(University Hospital Schleswig-Holstein), Yves Benoît(Ghent University Hospital), Rob Pieters(Princess Máxima Center), Jan Starý(Charles University), Vahid Asnafi(Hôpital Necker-Enfants Malades), Andrea Biondi(University of Milano-Bicocca), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), André Schrauder(University Hospital Schleswig-Holstein), Michael Kneba(Universitäts Hautklinik Kiel), Michael Dworzak(St. Anna Children's Cancer Research Institute), Oliver G. Ottmann(Cardiff University), D. Hoelzer(Oak Ridge National Laboratory), Nicola Gökbuget(Goethe University Frankfurt), Thorsten Raff(Goethe University Frankfurt), Elizabeth Macintyre(Inserm), Kjeld Schmiegelow(University of Copenhagen), Adele K. Fielding(New York Blood Center), Roman Pfeifer(Goethe University Frankfurt), A H Goldstone(Royal London Hospital), JM Ribera(Institut Català d'Oncologia), G. Janka‐Schaub(Universität Hamburg), A von Stackelberg(Royal London Hospital), Nick Goulden(Great Ormond Street Hospital), Hervé Dombret(University of London Institute in Paris), G. Henze(Charité - Universitätsmedizin Berlin)
Cited by 338
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k